VHIO is participating prominently in a study that seeks to evaluate the efficacy of a novel combination therapy in advanced pancreatic cancer

by Vall d’Hebron

The biopharmaceutical company Ability Pharmaceuticals, SL today announced the inclusion of the first patients in a phase 2b clinical trial with its novel autophagy-inducer anticancer compound ABTL0812...

Read more

Driving nano-based approaches closer to the clinic: Vall d’Hebron leads pilot study to assess the efficacy of nanoparticles against pancreatic cancer

by Vall d’Hebron

Nano-based drug delivery and anti-cancer therapy have shown promise in recent years as potential novel weaponry in the current arsenal of anti-cancer technologies. Nano-driven therapeutics involves th...

Read more

In celebration of today’s World Day against Pancreatic Cancer: spotlighting VHIO-led discovery

by Vall d’Hebron

​As a notoriously ‘silent’ disease in terms of identifiable symptoms, pancreatic cancer generally manifests itself at late and advanced stages, with only 20% of patients as candidates for curati...

Read more

CNIO and Columbia University co-lead a multidisciplinary project to study pancreatic cancer early detection

by CNIO - Centro Nacional de Investigaciones Oncológicas

The project aims to identify high-risk populations for pancreatic cancer, to include them in screening and early detection interventions so as to try to increase patients' survival rates

Read more

A gene that increases the risk of pancreatic cancer controls inflammation in normal tissue

by CNIO - Centro Nacional de Investigaciones Oncológicas

CNIO researchers discover that healthy cells suppress inflammation unless it is required. This finding suggests new strategies to improve the prevention of pancreatic cancer. The research is published...

Read more

Ability Pharmaceuticals Announces FDA-Orphan Drug Designation for ABTL0812 in Pancreatic Cancer

by Ability Pharma

Ability Pharmaceuticals, a drug development biopharmaceutical company specialized in oncology, announced today that has received orphan-drug designation (ODD) for ABTL0812 from the US Food and Drug Ad...

Read more

Dr. Schwartz Jr participates in a European nanomedicine project for pancreatic cancer

by Vall d’Hebron

The research comes as the results of an earlier European study which showed in animal models the efficacy of a therapeutic nanoconjugate against pancreatic cancer. Based on these results, the research...

Read more

Crowdfunding campaign for research into pesticides and cancer of the pancreas

by Universitat Autònoma de Barcelona (UAB)

A project conducted by the Hospital del Mar Medical Research Institute (IMIM) and the UAB to investigate whether certain pesticides and other environmental toxins contribute to pancreatic cancer has b...

Read more

The combination of chemotherapy and small electrical currents slows down the growth of pancreatic tumours

by UPF - Universitat Pompeu Fabra

The combination of TTFields and chemotherapy did demonstrate a delay in tumour growth compared to the animals treated only with chemotherapy (47% average relative reduction of tumour growth)

Read more

Pancreatic cancer: past, present and future of research and treatment

by CNIO - Centro Nacional de Investigaciones Oncológicas

Pancreatic cancer is rare, but it is one of the most deadly cancers with the highe st mortality rates, and one of the lowest 5 -­‐ year survival rates approaching 15 ­‐ 20%

Read more

UB researchers identify a key protein in pancreatic cancer development

by Universitat de Barcelona

Mutations of the KRAS gene occur in over 90% of pancreatic carcinomas. The gene helps the cell to interpret what is happening outside and indicates what actions must be done next, for instance to repr...

Read more

Modified vitamin D shows promise as treatment for pancreatic cancer

by Salk Institute for Biological Studies

Salk scientists find that a vitamin D-derivative makes tumors vulnerable to chemotherapy

Read more
Subscribe to Directory
Write an Article

Recent News

Tuneable reverse photochromes in the sol...

A new technique allows the design of solid materia...

La Unidad de Chequeos de la Clínica sup...

El estudio realizado sobre una muestra significati...

Highlight

Interview with Dámaso Molero, general m...

by 3P Biopharmaceuticals

Dámaso Molero: “There are great opportunities in Latin America for ...

by Labo'Life

Photos Stream